ADVANCED BILIARY TRACT CARCINOMA
Clinical trials for ADVANCED BILIARY TRACT CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED BILIARY TRACT CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED BILIARY TRACT CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo tested for tough-to-treat liver cancers
Disease control CompletedThis study tested whether combining an immunotherapy drug (SHR-1210) with either a targeted therapy (apatinib) or standard chemotherapy could help people with advanced liver or bile duct cancer. It involved 157 participants whose cancer had spread and was not suitable for surgery…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC
-
New drug duo tested for Tough-to-Treat bile duct cancer
Disease control CompletedThis study tested a combination of two drugs, pembrolizumab and lenvatinib, for people with advanced bile duct cancer that had worsened despite standard chemotherapy. The goal was to see if this drug pair could help control the cancer and was safe for patients. It involved 27 par…
Matched conditions: ADVANCED BILIARY TRACT CARCINOMA
Phase: PHASE2 • Sponsor: Shanghai Jiahui International Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC